Laboratoires Euromedis Société anonyme (EPA:ALEMG)
5.05
0.00 (0.00%)
Aug 12, 2026, 9:00 AM CET
EPA:ALEMG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 16.67 | 15.18 | 18.84 | 26.8 | 31.86 |
Cash & Short-Term Investments | 16.67 | 15.18 | 18.84 | 26.8 | 31.86 |
Cash Growth | 9.83% | -19.44% | -29.69% | -15.88% | 102.48% |
Accounts Receivable | 9.73 | 7.75 | 8.51 | 8.85 | 14.04 |
Other Receivables | - | - | 1.08 | 3.64 | 6.76 |
Total Trade Receivables | 9.73 | 7.75 | 9.59 | 12.48 | 20.8 |
Inventory | 0.53 | 1.83 | 10.81 | 12.59 | 11.76 |
Other Current Assets | - | - | 0.06 | - | - |
Total Current Assets | 38.24 | 37.65 | 39.24 | 51.87 | 64.41 |
Net Property, Plant & Equipment | 0.39 | 0.32 | 0.63 | 4.32 | 4.4 |
Other Intangible Assets | 0.25 | - | 0.03 | 2.63 | 2.77 |
Long-Term Investments | 0.06 | 0.06 | 6.3 | 1.05 | 1.15 |
Total Assets | 39.49 | 38.79 | 46.26 | 59.87 | 72.72 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 9.92 | 9.54 | 7.81 | 7.31 | 10.5 |
Accrued Expenses | - | - | 2.56 | 2.57 | 2.97 |
Other Current Liabilities | 2.93 | - | - | - | - |
Total Current Liabilities | 12.86 | 9.54 | 10.37 | 9.88 | 13.47 |
Long-Term Debt | 3.12 | 3.01 | 10.02 | 12.84 | 15.53 |
Other Long-Term Liabilities | 5.31 | 3.97 | 6.56 | 4.88 | 5.31 |
Total Long-Term Liabilities | 8.42 | 6.99 | 16.58 | 17.72 | 20.84 |
Total Liabilities | 21.28 | 16.53 | 20.39 | 22.71 | 29 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 5.77 | 5.75 | 5.75 | 6.02 | 6.02 |
Additional Paid-in Capital | 9.76 | 9.73 | 9.73 | 9.21 | 9.21 |
Accumulated Other Comprehensive Income | 2.63 | 2.63 | - | - | - |
Retained Earnings | -2.2 | 3.91 | 7.11 | 19.47 | 25.76 |
Total Common Shareholders' Equity | 15.97 | 22.02 | 22.59 | 34.7 | 41 |
Minority Interest | - | - | - | 0.18 | 0.24 |
Shareholders' Equity | 15.97 | 22.02 | 22.59 | 34.88 | 41.24 |
Total Liabilities & Equity | 39.49 | 38.79 | 46.26 | 59.87 | 72.72 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3.12 | 3.01 | 10.02 | 12.84 | 15.53 |
Net Cash (Debt) | 13.56 | 12.17 | 8.83 | 13.96 | 16.33 |
Net Cash Growth | 11.41% | 37.86% | -36.79% | -14.49% | - |
Net Cash Per Share | 0.02 | 0.56 | 3.07 | 4.64 | 5.42 |
Book Value | 15.97 | 22.02 | 22.59 | 34.7 | 41 |
Book Value Per Share | 0.02 | 1.02 | 7.86 | 11.53 | 13.62 |
Tangible Book Value | 15.72 | 22.02 | 22.56 | 32.07 | 38.23 |
Tangible Book Value Per Share | 0.02 | 1.02 | 7.85 | 10.65 | 12.70 |